A multicenter, dose-finding study to evaluate the safety and efficacy of CNTY-101 in patients with B cell-mediated autoimmune diseases (systemic lupus erythematosus and lupus nephritis).
Now Recruiting
Learn more about Century’s current Phase 1 clinical trial, CALiPSO-1, with study ID number: NCT06255028 at clinicaltrials.gov.